original_754613278.jpg

References

  1. Adams, D. L. et al. Circulating giant macrophages as a potential biomarker of solid tumors. Proc. Natl. Acad. Sci. U. S. A. 111, 3514–3519 (2014).

  2. Tang, C-M and Adams, D. L. Clinical Applications of Cancer-Associated Cells Present in the Blood of Cancer Patients. Biomedicines 10, 587 (2022).

  3. Adams, D. L. et al. Tracking changes in circulating stromal cells and circulating tumor cells predicts responsiveness of new line induction in metastatic breast cancer after 1 cycle of therapy. Journal of Clinical Oncology 40 (16_suppl), 3056-3056 (2022).

  4. Chumsri, S. et al. Peripheral blood biomarkers in Phase II study of pembrolizumab in combination with oral binimetinib in patients with unresectable locally advanced or metastatic triple-negative breast cancer. Cancer Res. 83, 5454–5454 (2023).

  5. Adams, D. L. et al. Mitosis in Circulating Tumor Cells stratifies highly aggressive breast carcinomas. Breast Cancer Research 18:44 (2016).

  6. Adams, D. L. et al. Enlarged Stromal Macrophages found in cancer patient blood are associated with more aggressive disease and poorer prognosis in localized stage I/II solid tumors, EDRN Annual Meeting 2021.

  7. Gironda, D. J. et al. Cancer Associated Macrophage-like Cells Are Prognostic for Highly Aggressive Prostate Cancer in Both the Non-Metastatic and Metastatic Settings. Cancers 15, 3725 (2023).

  8. Kasabwala, D. M. et al. Micronuclei in Circulating Tumor Associated Macrophages Predicts Progression in Advanced Colorectal Cancer. Biomedicines 10, 2898 (2022).

  9. Kasabwala, D. M. et al. Micronuclei in circulating stromal cells correlated with PD-L1 expression and predicts progression in metastatic breast cancer. Cancer Research 83, 304-304 (2023).

  10. Moran, J. A. et al. Extracellular vesicles budding from stromal macrophages in the blood of metastatic non-small cell lung cancer patients correlates with poor survival. Cancer Research 83, 3310-3310 (2023).

  11. Adams, D. L. et al. Tumor macrophage fusion cells detected in the circulation of metastatic breast cancer patients is prognostic for rapid progression and death. Cancer Research 83 (7_Supplement):2310-2310 (2023).

  12. Gardner, K. P. et al. Sequential monitoring of tumor macrophage fusion cells in the circulation of metastatic breast cancer and their prognostic value. ASCO Abstract #3054 (2023).

  13. Center for Devices & Radiological Health. List of Cleared or Approved Companion Diagnostic Devices (In Vitro and Imaging Tools). U.S. Food and Drug Administration (2023).

  14. Moran, J A. et al. Monitoring PD-L1 Expression on Circulating Tumor–Associated Cells in Recurrent Metastatic Non–Small-Cell Lung Carcinoma Predicts Response to Immunotherapy With Radiation Therapy. American Society of Clinical Oncology Abstract #8535 (2022).

  15. Gardner, K. P. et al. CXCR4 expression in tumor associated cells in blood is prognostic for progression and survival in pancreatic cancer. PLoS ONE 17(3): e0264763.